3654 results for «209»

Filter By

3654 results

CTO-PCI

07 Oct 2022 – From AICT-AsiaPCR 2022

Consider a 53-year-old man with a strong family history of MI, a history of exertion angina with cycling and dyslipidemia, or a 76-year-old male patient with hypertension, type 2 diabetes, previous CABG (2017), cholecystectomy (2018), left carotid endarterectomy (2018), left leg intervention (2018), and mild aortic...

CTO-PCI

Complex PCI with left ventricular support - Session with LIVE case

07 Oct 2022 – From AICT-AsiaPCR 2022

Look at this case of a 73-year-old man, heavy smoker, with hypertension, type 2 DM, and hyperlipidemia, who recently suffered class III effort-related angina and non-ST elevation MI, who presented with a totally occluded RCA, ulcerated LM, occluded LAD, and stenotic LCx, and study LIVE a complex PCI...

Complex PCI with left ventricular support

Surgical turndowns interventions and outcomes

07 Oct 2022 – From AICT-AsiaPCR 2022

Through this AICT AsiaPCR 2022 session, view a variety of case presentations and hear your peers discuss them to learn how to successfully manage high-risk PCI procedures.

Surgical turndowns interventions and outcomes

How to avoid and manage complications - Rupture and perforation

In this case-based discussion, learn with experts how to avoid major complications during PCI such as distal vessel perforation and mid vessel rupture, and through algorithms, how to manage them in case they occur.

Complications - Rupture and perforation

Tips, tricks and complications

08 Oct 2022 – From AICT-AsiaPCR 2022

Through 4 case examples, this discussion with experts will help you understand management strategies and problem solving for common and rare interventional complications. 

Tips, tricks and complications

How to deal with calcified coronaries

08 Oct 2022 – From AICT-AsiaPCR 2022

In this session, learn with experts about practical decisional algorithms to select the most appropriate tool in function of calcification severity and extension, and discover the contemporary tools and techniques for optimal plaque modification.

How to deal with calcified coronaries

AICT-AsiaPCR 2022's best clinical case and best abstract Awards

08 Oct 2022 – From AICT-AsiaPCR 2022

Percutaneous closure of a bleeding mycotic coronary artery aneurysm, superior vena cava aneurysm closed with an atrial septal defect device… Discover the best clinical cases and abstracts which were presented during AICT-AsiaPCR 2022.

Best clinical case and best abstract Awards

AICT-AsiaPCR 2022 Closing Ceremony

08 Oct 2022 – From AICT-AsiaPCR 2022

In this Closing Ceremony, Ashok Seth thanks all participants, Programme Committee Members, Faculty members and presenters, LIVE operating teams and Industry Partners for being part of this fantastic online and onsite edition of AICT-AsiaPCR 2022, while he highlights the key moments of the course.

AICT-AsiaPCR 2022 Closing Ceremony

SMT’s Hydra TAVR Valve demonstrates sustained safety, durability, and hemodynamic performance at 5 Years

19 Nov 2025

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

MASTER-DAPT: “the MASTER of high-bleeding risk trials”

28 Aug 2021

Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.

Luis Ortega-Paz

Author

Luis Ortega-Paz
ESC Congress 2021 - MASTER-DAPT : “the MASTER of high-bleeding risk trials”

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

HOST-EXAM:10-year follow-up of clopidogrel vs aspirin monotherapy in stable CAD after PCI with drug-eluting stent

30 Mar 2026

Nicola Ryan provides her take on the 10-year follow-up of the HOST-EXAM, which was presented by Hyo-Soo Kim at ACC.26 in New Orleans.

Nicola Ryan

Author

Nicola Ryan
10-year follow-up of clopidogrel vs aspirin monotherapy in stable coronary artery disease after percutaneous coronary intervention with drug-eluting stent
Didn’t find what you were looking for?